Long Focus Capital Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Long Focus Capital Management’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,147	Closed	-$34K	–	124
2022 Q3	$34K	Hold	3,147	–	–	﹤0.01%	106
2022 Q2	$51K	Hold	3,147	–	–	0.01%	110
2022 Q1	$80K	Hold	3,147	–	–	0.01%	105
2021 Q4	$66K	Buy	+3,147	New	+$106K	0.01%	101

Other funds holding ONCS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Long Focus Capital Management's ONCS Position: Q4 2022 in Review

Long Focus Capital Management sold out of OncoSec Medical Incorporated (ONCS) in Q4 2022, closing a stake of 3,147 shares — an estimated $34K sold.

Long Focus Capital Management first reported a position in ONCS in Q4 2021 and held it in 4 quarters. The position peaked at $80K in Q1 2022. 17 funds tracked by Wall St. Rank hold ONCS as of Q4 2022.

Long Focus Capital Management reported no remaining OncoSec Medical Incorporated position as of Q4 2022 after selling out during the quarter.
Long Focus Capital Management sold 3,147 OncoSec Medical Incorporated shares in Q4 2022, an estimated $34K.
Long Focus Capital Management first reported a position in OncoSec Medical Incorporated in Q4 2021 and held it in 4 quarters.
Long Focus Capital Management's OncoSec Medical Incorporated position peaked at $80K in Q1 2022.
17 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2022.

Based on Long Focus Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.